Name: Lessons From Landmark Medication Trials in Parkinson’s Disease – 0.5 CME
Start: 2025-06-27T09:30:00-0400
End: 2025-06-27T10:00:00-0400

Friday June 27, 2025 9:30am - 10:00am EDT

Woodrow Wilson B-D

Pharmacological treatment of Parkinson’s disease has evolved over time from the first landmark trials of L-dopa through today’s newer formulations and adjunctive medications. This session describes the landmark medication trials that every clinician should know and the major lessons drawn from each, with a focus on the evolution that has led to improved control of parkinsonian symptoms.

CME Faculty

Stuart H. Isaacson, MD, FAAN

Director, Parkinson’s Disease and Movement Disorders Center of Boca Raton

Stuart H. Isaacson, MD, FAAN is the Director of the Parkinson’s Disease and Movement Disorders Center of Boca Raton in Florida, USA. Dr. Isaacson received his medical degree from Northwestern University School of Medicine in Chicago, Illinois. He completed fellowships at the National... Read More →

Friday June 27, 2025 9:30am - 10:00am EDT
Woodrow Wilson B-D

CME General

ATMRD 2025

Stuart H. Isaacson, MD, FAAN

Log in to save this to your schedule, view media, leave feedback and see who's attending!